HLNE
$100.56
Hamilton Lane Incorporated is a private equity and venture capital firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies.
Recent News
Hamilton Lane, Ares, Affiliated Managers Group, Credit Acceptance, and Ally Financial Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the broader market advanced amid a more stable investor response to geopolitical tensions.
Is Hamilton Lane (HLNE) One of the Best Financial Stocks Right Now
Hamilton Lane Inc. (NASDAQ:HLNE) is one of the 10 best financial stocks with highest upside potential. As of the March 13 closing, consensus sentiment for Hamilton Lane Inc. (NASDAQ:HLNE) remained moderately bullish. The stock received coverage from 6 analysts, 4 of whom assigned Buy ratings and 2 gave Hold calls. With no Sell rating, it […]
Private Credit Funding Strain Tests Hamilton Lane’s Evolving Growth Story
JPMorgan Chase has started restricting lending to private credit providers, reflecting increased caution around the health of the private credit sector. These tighter funding conditions have raised liquidity concerns and contributed to redemption limits at several large private credit players. Hamilton Lane (NasdaqGS:HLNE), which has significant exposure to private credit, has seen its share price come under pressure as investors reassess risk. The market reaction highlights growing concern...
Moody's, Piper Sandler, StepStone Group, Hamilton Lane, and Capital One Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after investors raised concerns over the stability of the private credit market, following a key announcement from a major bank.
3 of Wall Street’s Favorite Stocks with Solid Fundamentals
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.